SMITH IAN F Insider Trades

Insider Trading History

Track insider trading activity for SMITH IAN F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $153k 28,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 28,000 shares
$4.08
$5.45
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $746k 77,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$512k 77,500 shares
$6.61
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $1.3M 134,705 shares
Last Trade
Apr 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.8k 3,441 shares
$7.49
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $99.3k 10,320 shares
Last Trade
Apr 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.8k 3,441 shares
$7.49
$9.62
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Executive Officer
Holding Value $5.77M 193,000 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6M 193,000 shares
$31.09
$29.91
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Executive Officer
Holding Value $3.86M 129,000 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.01M 129,000 shares
$31.09
$29.91
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.1k 4,573 shares
$5.49
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $1.26M 131,264 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.1k 4,573 shares
$5.49
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $173k 18,012 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.2k 18,012 shares
$5.45
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $132k 13,761 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75k 13,761 shares
$5.45
$9.62
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Executive Officer
Holding Value $17M 570,000 shares
Last Trade
Oct 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.4M 570,000 shares
$30.50
$29.91
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $44k 4,573 shares
Last Trade
Oct 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.1k 4,573 shares
$5.48
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $1.22M 126,692 shares
Last Trade
Oct 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.1k 4,573 shares
$5.48
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $88k 9,146 shares
Last Trade
Jul 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23k 4,573 shares
$5.03
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $1.17M 122,119 shares
Last Trade
Jul 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23k 4,573 shares
$5.03
$9.62
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $136k 25,000 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 25,000 shares
$4.79
$5.45
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $746k 77,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 77,500 shares
$4.58
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $1.13M 117,546 shares
Last Trade
Apr 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.2k 4,574 shares
$3.12
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $132k 13,719 shares
Last Trade
Apr 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.2k 4,574 shares
$3.12
$9.62
Stoke Therapeutics
Stoke Therapeutics STOK
Interim CEO
Holding Value $7.13M 238,420 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.99M 238,420 shares
$8.33
$29.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up